Rural Remote Health
COVID-19COVID-19 Drug TreatmentHealth Services Accessibility
Dr. Daniel Morton Soule, DO
NPI1861782633PAC ID0648414060
- Medicare services, 2024
- 160
- Medicare patients, 2024
- 72
- Part D claims, 2024
- 354
- Publications
- 1
- MIPS score, 2024
- 99
- Practice address
- 50 Leroy Street, Potsdam, NY 13676
- Practice phone
- Call (315) 265-3300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Soule's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Morton Soule is an infectious disease specialist in Potsdam, New York
Dr. Soule practices at Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health.
Dr. Soule's NPI, 1861782633, was assigned on April 14, 2011. Dr. Soule graduated from Arizona College of Osteopathic Medicine - Glendale in 2011. Dr. Soule holds New York license 284667.
NPI and contact details
- NPI
- 1861782633NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0648414060
- NPI enumeration date
- April 14, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (315) 265-3300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Morton Soule practices at Canton-Potsdam Hospital in Potsdam, New York
Dr. Soule's primary practice is Canton-Potsdam Hospital, at 50 Leroy Street, Potsdam, NY 13676 in St. Lawrence County. The practice phone is (315) 265-3300.
- Canton-Potsdam Hospital50 Leroy Street, Potsdam, NY 13676 · St. Lawrence CountyPhone(315) 265-3300
Source: Dmand AI Affiliation Data
Dr. Daniel Morton Soule is affiliated with 3 sites of care and 3 medical groups
Dr. Soule's primary practice is Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health. Dr. Soule is also affiliated with Massena Hospital. The medical group on file is Canton-Potsdam Hospital. Dmand AI also links Dr. Soule to 2 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Soule's employer is on file too: a hospital.
Massena HospitalCanton-Potsdam Hospital2 medical groupsNames with a free account1 group practice or clinicName with a free accountEmployer: hospitalName with a free account
See all 6 affiliations for Dr. SouleSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daniel Morton Soule's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soule practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Canton-Potsdam Hospital | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Soule practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Rochester Regional Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Morton Soule is one of 825 infectious disease specialists in New York
Infectious disease is Dr. Soule's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Soule is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Soule's licenses on file in 2 states: New York and Virginia.
Specialties and state licenses
- Infectious disease, New YorkPrimary
- Student in an organized health care education/training program, Virginia
Clinical focus
Dmand AI lists acute skin infection, hiv/aids, joint or bone infection, pneumonia, UTI and yeast infection among the conditions Dr. Soule treats.
Infectious disease specialists near Dr. Soule
Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Morton Soule billed Medicare for 160 services in 2024
CMS data shows 160 Medicare services from Dr. Soule across 6 procedure codes in 2024, for 72 Medicare patients. Medicare paid $12,985 for them.
Medicare services, 2024160
Medicare patients72
Paid by Medicare$12,985
Procedure codes6
Dr. Soule's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2342024: 16032%
Where Dr. Soule's Medicare services took place, 2024
- In an office6038%
- In a facility10063%
Dr. Soule compared with the New York median for infectious disease specialists, 2024
- Dr. Soule
- New York median
- Medicare services
- 160vs 23833% below
- Medicare patients
- 72vs 13446% below
- Part D claims
- 209vs 16229% above
Medians across 791 infectious disease specialists in New York with Dmand AI profiles that report each measure.
Dr. Soule's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Soule?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Soule and other infectious disease specialists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel Morton Soule treated 72 Medicare patients in 2024, average age 73
CMS counts 72 Medicare patients who saw Dr. Soule in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Soule's median patient age at 72, with 46% women.
Medicare patients, 202472
Average age73
Average risk score1.95
Also on Medicaid38%
Dr. Soule's Medicare patients by age, 2024
Dr. Soule's Medicare patients by sex, 2024
- Women2839%
- Men4461%
Chronic conditions among Dr. Soule's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis56%
- Anxiety47%
- Mood disorders44%
- COPD40%
- Depression39%
- Ischemic heart disease38%
Share of Medicare patients with each condition. A patient can have several.
Dr. Soule's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women46%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daniel Morton Soule wrote 354 Medicare Part D claims in 2024
In 2024, Dr. Soule wrote 354 Medicare Part D claims for 63 patients. 73% of them were for generic drugs. CMS names the drug for 209 of them, across 12 drugs with 11 or more claims each, at $162,389 in total drug cost. In 2023, CMS named 193 claims across 11 drugs.
Part D claims, 2024354
Drugs named by CMS12
Total drug cost$162,389
Part D patients63
Dr. Soule's Part D claims by kind of drug, 2024
- Generic258 claims73%
- Brand-name96 claims27%
Dr. Soule's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Soule's Part D claims, 2024
- Antibiotics39%139 of 354 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1932024: 2098%
Drugs named by CMS: 12 in 2024, 11 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daniel Morton Soule scored 99 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Soule for performance year 2024, reported through an alternative payment model (APM). Dr. Soule accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Soule as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Soule's MIPS scores, performance year 2024
- 99of 100Final score
- 87.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find infectious disease specialists like Dr. Soule by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel Morton Soule has 1 publication on record
Dmand AI links 1 paper to Dr. Soule in 2021. Dr. Soule's most frequent co-authors are Eyal Kedar, MD and Imre Kayvan Rainey-Spence, MD.
Papers1
Dr. Soule's most frequent co-authors
Recent publications by Dr. Soule
See who Dr. Soule researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Soule works with, so you can find a warm path to the right infectious disease specialists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel Morton Soule received $1,370 in industry payments from 2016 to 2025
CMS Open Payments shows 55 general payments to Dr. Soule from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Abbvie Inc. paid the most, $392.
General payments to Dr. Soule by program year, 2016 to 2025
General payments to Dr. Soule by kind, 2016 to 2025
$1.4Kin total
- Food and beverage$91066%
- Education$32824%
- Consulting fees$13210%
Companies that paid Dr. Soule the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daniel Morton Soule graduated from Arizona College of Osteopathic Medicine - Glendale
Dr. Soule graduated from Arizona College of Osteopathic Medicine - Glendale in 2011. Dr. Soule is a member of AOA.
- Medical school
- Board certified in infectious disease
- Board certified in internal medicine
- Board certified in 2011 - 2014
- Board certified in 2016 - 2025
- Board certified in 2014 - 2016
Source: Dmand AI Professional Profile Data
Dr. Daniel Morton Soule accepts plans from 17 insurance carriers
Dr. Soule is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Elevance
- HCSC
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- Blue Cross Blue Shield of Michigan
- Humana
- +9 more carriersWith a free account
Plan types Dr. Soule accepts, by number of carriers
- PPO11
- HMO7
- Medicare7
- EPO5
- POS3
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Daniel Morton Soule's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Morton Soule
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Morton Soule's NPI number?
Dr. Daniel Morton Soule's NPI number is 1861782633. It was assigned on April 14, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Morton Soule?
Dr. Daniel Morton Soule is an infectious disease specialist in Potsdam, New York. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).
Where does Dr. Daniel Morton Soule practice?
Dr. Soule practices at 50 Leroy Street, Potsdam, NY 13676. Dr. Soule's primary practice is Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health. Dmand AI also links Dr. Soule to 2 medical groups and 1 group practice or clinic.
What is Dr. Daniel Morton Soule's office phone number?
The practice phone on file for Dr. Soule is (315) 265-3300.
What is Dr. Daniel Morton Soule's medical license number?
Dr. Soule holds New York license 284667, one of the licenses on file in 2 states.
Which states has Dr. Daniel Morton Soule been licensed in?
Dmand AI has state licenses on file for Dr. Soule in New York and Virginia.
Which hospitals is Dr. Daniel Morton Soule affiliated with?
Dr. Soule practices at Canton-Potsdam Hospital in Potsdam, New York. Dr. Soule is also affiliated with Massena Hospital.
What medical group is Dr. Daniel Morton Soule part of?
Dr. Soule is linked to Canton-Potsdam Hospital. Dmand AI links Dr. Soule to 2 more medical groups.
Does Dr. Daniel Morton Soule accept Medicare?
Yes. CMS data shows Dr. Soule billed Medicare for 160 services in 2024, and Dr. Soule accepts Medicare assignment.
Does Dr. Daniel Morton Soule offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Soule as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Daniel Morton Soule's MIPS score?
Dr. Soule's MIPS final score for performance year 2024 is 99 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Daniel Morton Soule see?
CMS counts 72 Medicare patients who saw Dr. Soule in 2024, with an average age of 73.
Is Dr. Daniel Morton Soule board certified?
Yes. Dr. Soule is board certified in infectious disease by the American Board of Internal Medicine.
What services does Dr. Daniel Morton Soule bill to Medicare?
In 2024, Dr. Soule's most billed Medicare services were office visit, established patient (99213), hospital inpatient care (99232) and hospital inpatient care (99233).
Where did Dr. Daniel Morton Soule go to medical school?
Dr. Soule graduated from Arizona College of Osteopathic Medicine - Glendale in 2011.
What drugs does Dr. Daniel Morton Soule prescribe most?
In 2024 Medicare Part D data, Dr. Soule's most prescribed drugs by claims were Doxycycline Hyclate, Tenofovir Disoproxil Fumarate and Privigen.
Has Dr. Daniel Morton Soule received payments from drug or device companies?
CMS Open Payments shows $1,370 in general payments to Dr. Soule from 12 companies from 2016 to 2025. The largest total came from Abbvie Inc.
How long has Dr. Daniel Morton Soule been practicing?
Dr. Soule graduated from medical school in 2011, 15 years ago.
Does Dr. Daniel Morton Soule do research?
Dmand AI links 1 publication to Dr. Soule.
Who does Dr. Daniel Morton Soule publish with?
Dr. Soule's most frequent co-authors are Eyal Kedar, MD (1 shared paper) and Imre Kayvan Rainey-Spence, MD (1 shared paper).
What insurance does Dr. Daniel Morton Soule accept?
Dr. Soule is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
Selling to infectious disease practices?
See infectious disease specialists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card